Bharat Biotech releases Phase 3 trial results of Covaxin, claims vaccine efficacy of 78.8 pc against COVID-19
HYDERABAD: Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8...
India's vaccination coverage crosses landmark of 34 crore
NEW DELHI: India's cumulative COVID-19 vaccination coverage crossed the landmark of 34 crore on Friday. A total of 34,00,76,232 vaccine doses were administered till...
Zydus Cadila seeks emergency use authorisation for ZyCoV-D COVID-19 vaccine for 12 years, above
NEW DELHI: Pharmaceutical major Zydus Cadila on Thursday applied for Emergency Use Authorisation (EUA) seeking approval from the Drugs Controller General of India (DCGI)...
Russian President Putin attends a meeting of the Supreme Eurasian Economic Council via a video conference call outside Moscow
MOSCOW: Russian President Vladimir Putin on Wednesday disclosed that he had been inoculated with the Sputnik V coronavirus vaccine. "As for me, when I did...
Covaxin effectively neutralises both Alpha, Delta variants of Covid-US' top health institute
WASHINGTON: The National Institute of Health (NIH) in the United States has found that Bharat Biotech's COVAXIN vaccine generates antibodies that effectively neutralize both...
India seeks EU travel approval for Covishield Report
NEW DELHI: India's Serum Institute is seeking emergency authorisation in the European Union for its Covishield jab, the BBC reported. The move comes amid reports...
India reports less than 40,000 daily new COVID cases after 102 days, recovery rate increases to 96.87 pc
NEW DELHI: India on Tuesday reported 37,566 fresh COVID-19 cases, the first time in 102 days that daily cases dropped below the 40,000 mark,...
PRNE_Glenmark_Logo
MUMBAI:- Glenmark Pharmaceuticals Ltd (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Arformoterol Tartrate Inhalation Solution,...
COVID-19 vaccine shortage delays launch of universal inoculation drive in West Bengal
KOLKATA: The West Bengal government could not start its universal vaccination programme - aimed at inoculating people in the 18-45 age group free of...
DCGI's expert panel to review Phase III data of Covaxin today
NEW DELHI: The Subject Expert Committee (SEC) under the drug regulator will discuss reviewing the Phase III data of Bharat Biotech's Covaxin on Tuesday. The...